Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy

Running, not enrolling

Conditions studied: Metastatic Pancreatic Cancer

In brief

This is a study that aims to understand whether a blood test measuring tumor DNA circulating in the bloodstream (circulating tumor DNA; ctDNA) shows a similar response as observed by a follow-up CT scan. To study this question, ctDNA will be measured at the same times as CT scans (just before the start of treatment, as well as 2 months after), and the response measured by the ctDNA change will be compared to the response seen on the changes between the CT scans. The goal is to make sure that ctDNA response correlates well with CT scan response measurement.

Key facts

Study ID
NCT07122466
Run by
Northwell Health
People needed
24
Starts
2023-05-22
Expected to finish
2026-12-01
Last updated by the study team
2026-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.